Article

Recurrent corneal erosions clinical trial to begin

Cohasset, MA–Holles Laboratories is sponsoring a clinical trial of Dehydrex as a potential treatment for recurrent corneal erosions.

Cohasset, MA–Holles Laboratories is sponsoring a clinical trial of Dehydrex as a potential treatment for recurrent corneal erosions.

The trial is funded by an orphan drug grant from the FDA. It will compare the effects of Dehydrex to Bausch & Lomb's MoistureEyes.

Patients may qualify for the trial if they have a diagnosis of recurrent corneal erosion due to membrane dystrophy or post-traumatic abrasion, and have one documented episode within the past 4 months, as well as one prior episode.

The trial will give two out of three patients the Dehydrex, while the remaining third will receive the control treatment. Patients will take the medicines five times a day for 8 weeks.

Patients will be asked to have six visits over a 6-month period, and a telephone interview at 12 months. The patients' insurance carriers will be billed for office visits, while the study drug will be provided free of charge.

For more information, call John M.Szabocsik, PhD, at 312/553-0828 or 800/645-0996.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.